Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -59.995% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) O=[N+]([O-])c1ccc(CS(=O)(=O)c2ncn[nH]2)cc1
b) O=C(NCc1ccc(Cl)cc1)NCC(F)(F)F
c) Cc1c(Cc2ccccc2)c(=O)n2c([nH]c3ccccc32)c1C#N
d) Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1
Answer: d. Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1
Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1
[3-(4-methylphenyl)sulfonylimidazolidin-1-yl]-(4-nitrophenyl)methanone